AbCellera Biologics Inc.

NasdaqGS:ABCL Stock Report

Market Cap: US$803.4m

AbCellera Biologics Inc. Company Information

AbCellera Biologics Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: AbCellera Biologics Inc.
  • Ticker: ABCL
  • Exchange: NasdaqGS
  • Founded: 2012
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$803.396m
  • Shares Outstanding: 295.37m
  • Website: https://www.abcellera.com

Number of Employees

Location

  • AbCellera Biologics Inc.
  • 2215 Yukon Street
  • Vancouver
  • British Columbia
  • V5Y 0A1
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ABCLNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDDec 2020
8QQDB (Deutsche Boerse AG)YesCommon SharesDEEURDec 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/22 05:10
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.